Cancer Foundation

“Human Mitotic Centromere-Associated Kinesin Is Targeted by MicroRNA 485-5p/181c and Prognosticates Poor Survivability of Breast Cancer.” Journal Oncology 2019.

“Overexpression of ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.” Oncol Lett. 2019.

"FDA Guidance for Next Generation Sequencing-based Testing: Balancing Regulation and Innovation in Precision Medicine.” Nature Genomic Medicine. 2018

“Benefits and Harms of the Centers for Medicare & Medicaid Services Ruling on Results From Genome Sequencing.” JAMA Oncology. 2018

"Ribonucleotide reductase subunit M2B deficiency leads to mitochondrial permeability transition pore opening and is associated with aggressive clinicopathological manifestations of breast cancer.” Am J Transl Res. 2018

“An integrated bioinformational analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer.” Onco Targets Ther. 2018

“A homozygous variant in RRM2B  is associated with severe metabolic acidosis and early neonatal death.” Eur J Med Genetics 2018

“Novel common genetic susceptibility loci for colorectal cancer.” Journal of the National Cancer Institute. 2018

“Overexpression of Uridine-Cytidine Kinase 2 Correlates with Breast Cancer Progression and Poor Prognosis". J Breast Cancer. 2017

“Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers.” Carcinogenesis. 2017

“Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.” Oncol Report. 2017

“Preclinical effects of CRLX101, and investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis." Oncotarget. 2016

“Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.” Oncotarget. 2016